Chelsea Therapeutics gets a boost from upcoming request for Northepa’s approval

Chelsea Therapeutics International Ltd.’s (Nasdaq: CHTP) shares climbed 22% to $4.86 on April 18, after the biotechnology company revealed plans to file a New Drug Application (NDA) for its blood pressure drug candidate Northera in the third quarter. Moreover, the company agreed with the Food and Drug Administration that the application would be submitted based on the results of the first - Continue Reading »

Amylin Pharmaceuticals recovers on EU recommendation; poised to dip as Q1 results miss estimates

Amylin Pharmaceuticals Inc. (Nasdaq: AMLN) shares surged 16% on April 15, after the company reported that its experimental diabetes drug Bydureon (exenatide once-weekly) has been recommended for approval by Europe’s Committee for Medicinal Products for Human Use. The drug candidate is developed in a partnership with Alkermes (Nasdaq: ALKS) and Eli Lilly (NYSE: LLY) and represents a once-weekly, injectable version - Continue Reading »

Top Tech Stock; Research In Motion rolls through Mixed Playbook Reviews

Shares of Research In Motion Limited (NASDAQ:RIMM) shares today recovered the slight losses yesterday after the company got mediocre reviews on its tablet computer PlayBook, ahead of the scheduled launch on April 19. Reviewers consented that the tablet offers some advantages mainly to business customers, however it would fail to impress the mainstream clients and needs additional functionality to successfully - Continue Reading »

Smokin’ Stock on the Move; Star Scientific rallies as Investors Temper

Star Scientific Inc. (Nasdaq: CIGX) shares pulled back 28% this month, after the company gained more than 150% last March to hit a 52-week high of $5.12 on April 4. The downward correction came after investors softened their expectations and recognized that the company is still selling promises and hopes that are far away from materialization. Boosted by the favorable Food and - Continue Reading »

Hot Stock Alert – Riverbed breaks from Downward Trend by Topping Consensus Estimates

Riverbed Technology Inc.’s (NASDAQ: RVBD) shares surged nearly 15% this morning after the company raised its outlook for Q1 2011 above consensus estimates and weathered away the rumors that its results could miss expectations. RVBD climbed to $35.20, after ending the regular session down 6.5% to $30.92. RVBD reported that it now expects adjusted earnings of $0.19 to $0.20 a - Continue Reading »

Alcoa plunges on Revenue Miss; Pricing Momentum could Trigger Upturn

Alcoa Inc. (NYSE: AA) shares dropped more than 4% after the aluminum producer posted first-quarter revenue that felt short of market expectations. The revenue miss contrasts the double-digit growth in demand and strong aluminum prices during the first quarter of 2011, but is a logical consequence of a bunch of upward revisions in 2011 result estimates that analysts carried over - Continue Reading »

Biopharm Stock on the Move; BioCryst rebounds on Rumors of increased Influenza Incidence

BioCryst Pharmaceuticals Inc. (NASDAQ: BCRX) shares recovered 16% in the second half of March, on speculations that the increased flu incidence this spring as well as bigger government stockpiling could boost the sales of the company’s influenza drug Peramavir. In addition, the earthquake and subsequent tsunami in Japan created the circumstances for increased transmission of influenza virus through the high - Continue Reading »

Banking Stock – Moment of Truth for the Bank of Ireland: To recapitalize or not?

Shares  of The Governor and Company of The Bank of Ireland (NYSE: IRE) are suspended from trading today on the Irish stock exchange pending the publication of crunch stress tests and subsequent announcements concerning the potential recapitalization of the bank. The newly established government of Ireland is expected to unveil a plan of dealing with its banking crisis and convince - Continue Reading »

Stock Alert for JA Solar Holdings Co. Ltd. (ADR)(JASO)

JA Solar Holdings Co. Ltd. (JASO) is a leading manufacturer of high-performance solar power products. The Company sells its products to solar manufacturers worldwide, who assemble and integrate solar cells into modules and systems that convert sunlight into electricity for residential, commercial and utility-scale power generation. The Company recorded total shipments of 1.46GW (gigawatt) in 2010, representing an increase of - Continue Reading »

Hot Stock Alert – Netlist climbs on 3 Patents Award

Shares of Netlist Inc. (Nasdaq: NLST) surged 9.1% in the afterhours session on March 29, after the company reported that it received three patents related to its HyperCloud Memory technology. The stock closed the regular session at $2.42 and reached $2.64 during the extended trading. With a 52-week range of $1.81-$3.90, the March 29 trade is in the middle of - Continue Reading »